Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DL-AP7, a competitive NMDA antagonist and anticonvulsant, blocks NMDA-induced convulsions and impairs learning performance in mice during a passive avoidance task [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | Inquiry | |
50 mg | Inquiry | Inquiry | |
100 mg | Inquiry | Inquiry |
Description | DL-AP7, a competitive NMDA antagonist and anticonvulsant, blocks NMDA-induced convulsions and impairs learning performance in mice during a passive avoidance task [1]. |
In vivo | DL-AP7, when administered intracerebroventricularly (ICV), inhibits convulsions triggered by NMDA with an effective dose (ED 50) of 0.22 nmol/mouse. Additionally, it detrimentally affects the ability of mice to learn in a passive avoidance task [1]. |
Molecular Weight | 225.181 |
Formula | C7H16NO5P |
CAS No. | 85797-13-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
1eq. NaOH: 100 mM
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
DL-AP7 85797-13-3 Others DL AP7 DL-AP-7 DLAP7 inhibitor inhibit